Post

M&A | Clariant and CD&R are reportedly in talks to acquire Ashland in an all-cash deal, Bloomberg News reported on Sunday. The talks, cited to people familiar with the matter, would pair Swiss specialty chemicals maker Clariant with private equity firm Clayton, Dubilier & Rice. Ashland, a US maker of additives and specialty ingredients for life sciences, personal care and coatings, has been exploring a sale since August after pressure from activist investors. A Clariant–CD&R consortium had already submitted initial bids in early October, according to ION Analytics, while rival interest from Evonik has since cooled, Bloomberg reported earlier this month. No price or terms have been disclosed, and the companies have not commented. Reuters said it could not immediately verify the report. A deal would combine two specialty portfolios with overlapping personal-care businesses — an overlap analysts have flagged as a likely antitrust consideration. Source: Bloomberg News via Reuters (22 November 2026)

4:35:59 AM · Nov 23, 2026
Sign in to reply and join the conversation.